Castle Biosciences Newsroom

Castle Biosciences Is Maintained at Sector Outperform by Scotiabank

Dow JonesNov 6 11:01 ET

Castle Biosciences Analyst Ratings

BenzingaNov 6 10:51 ET

Scotiabank Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44

Moomoo NewsNov 6 08:31 ET

Strong Growth Prospects and Financial Health Support Buy Rating for Castle Biosciences

TipRanksNov 6 03:21 ET

BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $45

Moomoo NewsNov 5 16:33 ET

Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $40

Moomoo NewsNov 5 09:35 ET

Castle Biosciences (CSTL) Gets a Buy From Lake Street

TipRanksNov 5 09:02 ET

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsNov 5 07:36 ET

Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $39

Moomoo NewsNov 5 07:36 ET

Castle Biosciences Is Maintained at Outperform by Baird

Dow JonesNov 5 07:09 ET

Castle Biosciences Analyst Ratings

BenzingaNov 5 07:01 ET

KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $36

Moomoo NewsNov 5 05:33 ET

Castle Biosciences Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 29 08:29 ET

Castle Biosciences Analyst Ratings

BenzingaOct 29 08:18 ET

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $42

Moomoo NewsOct 29 07:31 ET

Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $34

Moomoo NewsOct 16 09:35 ET

BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $40

Moomoo NewsOct 15 06:31 ET

Castle Biosciences' TissueCypher Gains Buy Rating Due to Market Potential and Medicare Reimbursement

TipRanksOct 15 06:19 ET

Castle Biosciences Analyst Ratings

BenzingaOct 14 11:10 ET

Castle Biosciences (CSTL) Receives a Buy From Scotiabank

TipRanksAug 7 08:37 ET